期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Reversing metabolic reprogramming by CPT1 inhibition with etomoxir promotes cardiomyocyte proliferation and heart regeneration via DUSP1 ADP-ribosylationmediated p38 MAPK phosphorylation
1
作者 Luxun Tang Yu Shi +10 位作者 Qiao Liao Feng Wang Hao Wu Hongmei Ren Xuemei Wang Wenbin Fu Jialing Shou Wei Eric Wang pedro ajose Yongjian Yang Chunyu Zeng 《Acta Pharmaceutica Sinica B》 2025年第1期256-277,共22页
The neonatal mammalian heart has a remarkable regenerative capacity,while the adult heart has difficulty to regenerate.A metabolic reprogramming from glycolysis to fatty acid oxidation occurs along with the loss of ca... The neonatal mammalian heart has a remarkable regenerative capacity,while the adult heart has difficulty to regenerate.A metabolic reprogramming from glycolysis to fatty acid oxidation occurs along with the loss of cardiomyocyte proliferative capacity shortly after birth.In this study,we sought to determine if and how metabolic reprogramming regulates cardiomyocyte proliferation.Reversing metabolic reprogramming by carnitine palmitoyltransferase 1(CPT1)inhibition,using cardiac-specific Cpt1a and Cpt1b knockout mice promoted cardiomyocyte proliferation and improved cardiac function post-myocardial infarction.The inhibition of CPT1 is of pharmacological significance because those protective effects were replicated by etomoxir,a CPT1 inhibitor.CPT1 inhibition,by decreasing poly(ADP-ribose)polymerase 1 expression,reduced ADP-ribosylation of dual-specificity phosphatase 1 in cardiomyocytes,leading to decreased p38 MAPK phosphorylation,and stimulation of cardiomyocyte proliferation.Our present study indicates that reversing metabolic reprogramming is an effective strategy to stimulate adult cardiomyocyte proliferation.CPT1 is a potential therapeutic target for promoting heart regeneration and myocardial infarction treatment. 展开更多
关键词 Metabolic reprogramming Cardiomyocyte proliferation Carnitine palmitoyltransferase l ETOMOXIR Fatty acid oxidation GLYCOLYSIS ADP-RIBOSYLATION p38 MAPK
原文传递
Gastrin attenuates sepsis-induced myocardial dysfunction by down-regulation of TLR4 expression in macrophages 被引量:8
2
作者 Dandong Fang Yu Li +15 位作者 Bo He Daqian Gu Mingming Zhang Jingwen Guo Hongmei Ren Xinyue Li Ziyue Zhang Ming Tang Xingbing Li Donghai Yang Chunmei Xu Yijie Hu Hongyong Wang pedro ajose Yu Han Chunyu Zeng 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2023年第9期3756-3769,共14页
Myocardial dysfunction is the most serious complication of sepsis.Sepsis-induced myocardial dysfunction(SMD)is often associated with gastrointestinal dysfunction,but its pathophysiological significance remains unclear... Myocardial dysfunction is the most serious complication of sepsis.Sepsis-induced myocardial dysfunction(SMD)is often associated with gastrointestinal dysfunction,but its pathophysiological significance remains unclear.The present study found that patients with SMD had higher plasma gastrin concentrations than those without SMD.In mice,knockdown of the gastrin receptor,cholecystokinin B receptor(Cckbr),aggravated lipopolysaccharide(LPS)-induced cardiac dysfunction and increased inflammation in the heart,whereas the intravenous administration of gastrin ameliorated SMD and cardiac injury.Macrophage infiltration plays a significant role in SMD because depletion of macrophages by the intravenous injection of clodronate liposomes,48 h prior to LPS administration,alleviated LPSinduced cardiac injury in Cckbr-deficient mice.The intravenous injection of bone marrow macrophages(BMMs)overexpressing Cckbr reduced LPS-induced myocardial dysfunction.Furthermore,gastrin treatment inhibited toll-like receptor 4(TLR4)expression through the peroxisome proliferator-activated receptor a(PPAR-a)signaling pathway in BMMs.Thus,our findings provide insights into the mechanism of the protective role of gastrin/CCKBR in SMD,which could be used to develop new treatment modalities for SMD. 展开更多
关键词 Sepsis-induced myocardial dysfunction GASTRIN Cholecystokinin B receptor Macrophage Toll-like receptor 4 Peroxisome proliferatorsactivated receptor a Lipopolysaccharide Inflammation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部